RxDoctor Payments Data

Cassandra Cunnien

Psychiatric/Mental Health · Kissimmee, FLNPI 1275187924

Payments from drug & device makers

$4,979in general payments, 2019–2025

Across 237 payments — averaging $21.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$1K
  • AbbVie$1K
  • Otsuka America Pharmaceutical, Inc.$602
  • Johnson & Johnson$478
  • Supernus Pharmaceuticals, Inc.$316
  • Vanda Pharmaceuticals Inc.$292
  • plus $1K from 12 others

What the payments were for

  • Food & beverage$4,94799%
  • Education$321%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,979 in reported general payments places this provider in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole37$91,318
LybalviOlanzapine/Samidorphan Malate26$43,474
VraylarCariprazine Hcl23$33,355
Invega SustennaPaliperidone Palmitate16$30,038
Lurasidone Hcl36$28,135
RexultiBrexpiprazole15$15,489
Divalproex Sodium ErDivalproex Sodium32$3,616
Vilazodone Hcl27$3,184
Olanzapine62$3,016
Buspirone Hcl111$2,015
Atomoxetine Hcl12$1,544
Oxcarbazepine19$1,136
Aripiprazole47$1,128
Duloxetine Hcl42$1,083
Benztropine Mesylate53$927

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$602$106,80752 claims
Alkermes, Inc.Lybalvi$1,251$43,47426 claims
AbbVieVraylar$1,020$33,35523 claims
Johnson & JohnsonInvega Sustenna$478$30,03816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Kissimmee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →